Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Metrics: PDF 1586 views | HTML 1318 views | ?
Ki-Eun Hwang1,*, Young-Suk Kim1,*, Jae-Wan Jung1, Su-Jin Kwon1, Do-Sim Park2, Byong-Ki Cha3, Seon-Hee Oh4, Kwon-Ha Yoon5, Eun-Taik Jeong1, Hak-Ryul Kim1
1Department of Internal Medicine, Institute of Wonkwang Medical Science, Wonkwang University, School of Medicine, Iksan, Jeonbuk, Korea
2Department of Laboratory Medicine, Wonkwang University, School of Medicine, Iksan, Jeonbuk, Korea
3Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School, Jeonju, Jeonbuk, Korea
4Department of Natural Medical Sciences, College of Health Science, Chosun University, Seosuk-dong, Gwangju, Korea
5Department of Radiology, Wonkwang University School of Medicine, Iksan, Jeonbuk, Korea
*These authors have contributed equally to this work
Hak-Ryul Kim, e-mail: email@example.com
Keywords: autophagy, apoptosis, pemetrexed, simvastatin
Received: March 30, 2015 Accepted: August 10, 2015 Published: August 20, 2015
Pemetrexed, a multitarget antifolate used to treat malignant mesothelioma and non-small cell lung cancer (NSCLC), has been shown to stimulate autophagy. In this study, we determined whether autophagy could be induced by pemetrexed and simvastatin cotreatment in malignant mesothelioma and NSCLC cells. Furthermore, we determined whether inhibition of autophagy drives apoptosis in malignant mesothelioma and NSCLC cells. Malignant mesothelioma MSTO-211H and A549 NSCLC cells were treated with pemetrexed and simvastatin alone and in combination to evaluate their effect on autophagy and apoptosis. Cotreatment with pemetrexed and simvastatin induced greater caspase-dependent apoptosis and autophagy than either drug alone in malignant mesothelioma and NSCLC cells. 3-Methyladenine (3-MA), ATG5 siRNA, bafilomycin A, and E64D/pepstatin A enhanced the apoptotic potential of pemetrexed and simvastatin, whereas rapamycin and LY294002 attenuated their induction of caspase-dependent apoptosis. Our data indicate that pemetrexed and simvastatin cotreatment augmented apoptosis and autophagy in malignant mesothelioma and NSCLC cells. Inhibition of pemetrexed and simvastatin-induced autophagy was shown to enhance apoptosis, suggesting that this could be a novel therapeutic strategy against malignant mesothelioma and NSCLC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.